APA (7th ed.) Citation

Lai, G., Li, J., Wang, S., Chen, C., Yang, C., Lin, C., . . . Yang, S. (2024). Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database. PLoS ONE, 19(3), 1. https://doi.org/10.1371/journal.pone.0299102

Chicago Style (17th ed.) Citation

Lai, Gu-Shun, Jian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, Chun-Kuang Yang, Chia-Yen Lin, Sheng-Chun Hung, Kun-Yuan Chiu, and Shun-Fa Yang. "Outcome Benefits of Upfront Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: An Analysis of the TriNetX Database." PLoS ONE 19, no. 3 (2024): 1. https://doi.org/10.1371/journal.pone.0299102.

MLA (9th ed.) Citation

Lai, Gu-Shun, et al. "Outcome Benefits of Upfront Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: An Analysis of the TriNetX Database." PLoS ONE, vol. 19, no. 3, 2024, p. 1, https://doi.org/10.1371/journal.pone.0299102.